MiMedx
MiMedx Announces Securities and Exchange Commission Settlement
MiMedx Group, Inc. announced that it has finalized a settlement with the Securities and Exchange Commission (the "SEC"), resolving a previously disclosed investigation into the Company's financial accounting practices.
MiMedx Announces Resignation of Board Member
MiMedx Group, Inc. (OTC PINK: MDXG) ("MiMedx" or "the Company"), an industry leader in advanced wound care and an emerging therapeutic biologics company, today announced that Luis A. Aguilar has notified the Company of his resignation from the Board of Directors. The Board expresses its appreciation for his service.
MiMedx Announces BDO as the Company’s New Independent Registered Public Accounting Firm
MiMedx Group, Inc. (OTC PINK: MDXG), an industry leader in advanced wound care and an emerging therapeutic biologics company, today announced that the Audit Committee of the Company's Board of Directors approved the engagement of BDO USA, LLP ("BDO") as the Company's new independent registered public accounting firm. BDO delivers assurance and tax advisory services to clients throughout the country and around the globe, and is the 5th largest firm in the world serving publicly traded domestic and international clients.